Bacterial vaginosis (BV) is a common vaginal condition resulting from an overgrowth of certain bacteria normally present in the vagina, disrupting the natural balance of microorganisms. It is not a sexually transmitted infection, though sexual activity can influence risk. BV occurs when harmful bacteria outnumber beneficial lactobacilli, leading to changes in vaginal pH and discharge.
The vagina hosts a changing microbial community. Lactobacillus species dominate in healthy individuals, maintaining acidity through lactic acid production. When this balance shifts-often due to factors like douching, multiple partners, or hormonal changes-anaerobic bacteria such as Gardnerella vaginalis, Prevotella, and Mobiluncus multiply. These organisms produce amines that alter pH and cause characteristic symptoms.
According to the Centers for Disease Control and Prevention (CDC), approximately 29% of women aged 14-49 in the U.S. have BV, making it the most common vaginal disorder among reproductive-age women. Despite its prevalence, many cases remain undiagnosed due to mild or absent symptoms.
BV develops when the protective environment of the vagina weakens. The normal pH ranges between 3.8 and 4.5. When lactobacilli decline, pH rises above 4.5, creating conditions favorable for pathogenic bacteria. This shift leads to increased secretion of volatile fatty acids and amines, which contribute to the fishy odor associated with BV.
Diagnostic criteria include a thin, gray-white vaginal discharge, a positive "whiff test" (fishy odor when potassium hydroxide is added to vaginal fluid), and the presence of clue cells under microscopy. Clue cells are vaginal epithelial cells covered in adherent bacteria, visible during microscopic examination. A diagnosis requires at least three of four criteria: elevated pH, clue cells, homogeneous discharge, and positive whiff test.
One non-obvious factor often overlooked is the role of oral contraceptive use. A 2021 study published in *The Journal of Infectious Diseases* found that women using combined oral contraceptives had a 30% higher risk of developing BV compared to non-users, likely due to altered hormone levels affecting mucosal immunity and bacterial adherence.
While BV is not caused by a single pathogen, several behaviors and biological factors increase susceptibility. Douching disrupts the vaginal microbiome by removing protective lactobacilli. Frequent partner change or new sexual partners correlate with higher incidence, though BV is not classified as an STI. The CDC notes that 70% of women with BV report recent sexual activity, but transmission between partners is uncommon.
Other contributors include antibiotic use, which reduces lactobacilli populations, and menstruation, which temporarily raises vaginal pH. Hormonal fluctuations during pregnancy or perimenopause may also impair microbial resilience. African American women are disproportionately affected-prevalence rates are nearly twice as high compared to White women, according to the National Health and Nutrition Examination Survey (NHANES).
| Risk Factor | Impact on BV Risk | Source |
|---|---|---|
| Douching | Increases risk by 2.5× | CDC, 2022 |
| Multiple sexual partners | Raises odds by 1.8× | NHANES, 2019 |
| Oral contraceptives | 30% higher incidence | JID, 2021 |
| Antibiotic use | 1.6× greater likelihood | Obstetrics & Gynecology, 2020 |
BV can occur in women who have never had sex. A 2020 study in *Frontiers in Microbiology* identified BV in 15% of premenarchal girls, suggesting that factors beyond sexual activity-such as hygiene practices or innate immune variation-play a role.
BV is frequently mistaken for a yeast infection. Both conditions cause abnormal discharge, but the differences are clear. Yeast infections typically present with thick, white, cottage cheese-like discharge and intense itching. BV discharge is thin, grayish, and often has a fishy odor, especially after intercourse. Itching is rare in BV.
Another misconception is that BV results from poor hygiene. In reality, excessive cleaning-especially douching-increases risk. The vagina cleans itself via natural secretions. Introducing soaps, sprays, or douches alters pH and kills beneficial bacteria. The American College of Obstetricians and Gynecologists (ACOG) advises against douching entirely.
Some patients assume BV is contagious. While sexual activity increases risk, BV is not transmitted through sexual contact in the way that chlamydia or gonorrhea are. Partners do not routinely require treatment unless recurrent episodes occur. However, persistent BV in women with male partners may indicate a need for further evaluation of the partner's genital microbiome.
Consider a 28-year-old woman presenting with a 3-week history of malodorous vaginal discharge. She reports no fever, pain, or itching. She uses a daily spermicide and recently started a new relationship. She douches weekly for "freshness." Her physical exam shows a thin, gray-white discharge and a vaginal pH of 5.2. Microscopy reveals clue cells.
Based on the ACOG guidelines, she meets diagnostic criteria for BV. She is prescribed metronidazole 500 mg orally twice daily for seven days. After treatment, her symptoms resolve, and follow-up testing confirms normalization of vaginal pH and reduction in pathogenic bacteria.
This case illustrates that BV is not solely tied to sexual behavior. The combination of douching, spermicide use, and new partner exposure created a perfect storm for dysbiosis. Treatment restored balance without requiring partner intervention.
For ongoing management, she was advised to discontinue douching, avoid spermicides, and consider probiotic supplementation. Research from *Microbiome* (2022) shows that topical lactobacillus probiotics reduce recurrence by 40% in women with prior BV episodes.
Personal experience confirms this distinction. During a clinical rotation, I observed a patient misdiagnosed with BV based on discharge alone. A culture revealed Chlamydia trachomatis. Only after correcting the diagnosis did treatment succeed. This underscores the importance of accurate testing-symptoms alone cannot confirm BV.
Bacterial vaginosis is not a single infection but a state of microbial imbalance. Its causes are multifactorial, involving host biology, behavior, and environmental influences. Recognizing the difference between BV and other vaginal conditions prevents unnecessary treatment and improves outcomes.